RAPT Therapeutics Strengthens Leadership Team with Two New
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based...
Source: globenewswire.com
Page 14 - Kronos Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kronos Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kronos Bio Today - Breaking & Trending Today
RAPT Therapeutics Strengthens Leadership Team with Two New Key Hires
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 -- RAPT Therapeutics, Inc. , a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral... | September 28, 2022
Source: marketscreener.com
Kronos Bio Announces Participation in H.C. Wainwright 24th Annual Global Investment Conference
06.09.2022 - SAN MATEO, Calif. and CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) - Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer and other serious diseases, today announced participation in the ...
Source: wallstreet-online.de
Brii Biosciences Appoints Taiyin Yang to Board of Directors, Strengthening Product Quality Oversight to Support Company Momentum
/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a multi-national company developing innovative therapies for...
Source: prnewswire.com
Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML
Companion diagnostic would be used following potential regulatory approval of entospletinib to screen for NPM1 mutation present in approximately one-third of all patients with AML Entospletinib is currently being studied in the Phase 3 AGILITY registrational study, with data anticipated in second half of 2023 SAN MATEO, Calif. and SAN DIEGO, Aug. 17, 2022 /PRNewswire/ -- Kronos Bio, Inc....
Source: asiaone.com